Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15105900)

  • 1. [Report of the National Oncology Research and Developement Consortium, 2003].
    Tímár J
    Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Report on the first year of the activity of the National Oncological RD Consortium].
    Tímár J
    Magy Onkol; 2002; 46(4):297-300. PubMed ID: 12563351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activity of the National Oncology R&D Consortium in 2004].
    Tímár J;
    Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
    Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
    Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarkers in solid tumors].
    Nagy Z
    Magy Onkol; 2013 Mar; 57(1):56-62. PubMed ID: 23573523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative measurement of iNOS expression in melanoma, nasopharyngeal, colorectal, and breast tumors of Tunisian patients: comparative study and clinical significance.
    Dabbeche-Bouricha E; Hadiji-Abbes N; Abdelmaksoud-Damak R; Alaya N; Ayadi W; Charfi S; Khabir A; Sellami-Boudawara T; Mokdad-Gargouri R
    Tumour Biol; 2016 Apr; 37(4):5153-64. PubMed ID: 26547585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
    Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
    Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia.
    Bai AH; Tong JH; To KF; Chan MW; Man EP; Lo KW; Lee JF; Sung JJ; Leung WK
    Int J Cancer; 2004 Dec; 112(5):846-53. PubMed ID: 15386372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring metastatic behavior of human tumor cells in mice with species-specific polymerase chain reaction: elevated expression of angiogenesis and bone resorption stimulators by breast cancer in bone metastases.
    van der Pluijm G; Sijmons B; Vloedgraven H; Deckers M; Papapoulos S; Löwik C
    J Bone Miner Res; 2001 Jun; 16(6):1077-91. PubMed ID: 11393785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome.
    Risinger JI; Barrett JC; Watson P; Lynch HT; Boyd J
    Cancer; 1996 May; 77(9):1836-43. PubMed ID: 8646682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
    Fleisher AS; Esteller M; Harpaz N; Leytin A; Rashid A; Xu Y; Liang J; Stine OC; Yin J; Zou TT; Abraham JM; Kong D; Wilson KT; James SP; Herman JG; Meltzer SJ
    Cancer Res; 2000 Sep; 60(17):4864-8. PubMed ID: 10987299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.